2 unknown. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Unknown 2 |
| Phase 2 | 1 | Unknown 1 |
Follow T2D: new trials by email Literature Review of T2D trials Research Report on T2D
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study on the Efficacy and Safety of Chiglitazar Sodium in PCOS With T2DM pioglitazone group: lifestyle intervention+ metformin+ orlistat (obese patients)+ pioglitazone, the Chiglitazar group: lifestyle intervention+ metformin+ orlistat (obese patients)+ Chiglitazar - PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries, T2D | Phase 1 | Unknown | Affiliated Hospital of Nantong University | 142 | 2022-10-01 | 2023-08-01 |
| BM-MNC and UCMSC for Type 2 Diabetes Mellitus Patients Bone-marrow aspiration, Intra-pancreatic Catheterisation of BM-MNC, Intravenous Infusion of UC-MSC - T2D | Phase 1 / Phase 2 | Unknown | Universitas Indonesia | 15 | 2016-03-14 | 2020-08-06 |
Diabetes Mellitus, Type 2 (1) · Polycystic Ovary Syndrome (1)
Endocrine System Diseases (2) · Adnexal Diseases (1) · Cysts (1) · Diabetes Mellitus (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genital Diseases (1) · Genital Diseases, Female (1) · Glucose Metabolism Disorders (1) · Gonadal Disorders (1) · Metabolic Diseases (1) · Neoplasms (1) · Nutritional and Metabolic Diseases (1) · Ovarian Cysts (1) · Ovarian Diseases (1)
Affiliated Hospital of Nantong University (1) · Universitas Indonesia (1)
China (1) · Indonesia (1)